Patents by Inventor Steve Nanchen

Steve Nanchen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20190380981
    Abstract: The present invention concerns the use of lufenuron for controlling sea lice in a fish population, which comprises feeding lufenuron to the fish population according to a specific regime as outlined in the specification and claims. The process is especially suited for the treatment of salmon and provides prolonged effective protection against sea lice at sea.
    Type: Application
    Filed: August 30, 2019
    Publication date: December 19, 2019
    Inventors: David Blaser, Jacques Bouvier, Martin Fink, John Gerard McHenery, Steve Nanchen
  • Patent number: 10040785
    Abstract: The present invention concerns compounds of formula (I) or an N-oxide or salt thereof and their use for controlling parasites in and on warm-blooded animals or fish.
    Type: Grant
    Filed: February 5, 2018
    Date of Patent: August 7, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noëlle Gauvry, Thomas Goebel, Steve Nanchen, Jean-Luc Perret, Ulrich Roos, Sandra Schorderet Weber
  • Publication number: 20180155331
    Abstract: The present invention concerns compounds of formula (I) or an N-oxide or salt thereof and their use for controlling parasites in and on warm-blooded animals or fish.
    Type: Application
    Filed: February 5, 2018
    Publication date: June 7, 2018
    Inventors: Noëlle Gauvry, Thomas Goebel, Steve Nanchen, Jean-Luc Perret, Ulrich Roos, Sandra Schorderet Weber
  • Patent number: 9920037
    Abstract: The present invention concerns compounds of formula (I) or an N-oxide or salt thereof and their use for controlling parasites in and on warm-blooded animals or fish.
    Type: Grant
    Filed: November 6, 2015
    Date of Patent: March 20, 2018
    Assignee: Elanco Tiergesundheit AG
    Inventors: Noëlle Gauvry, Thomas Goebel, Steve Nanchen, Jean-Luc Perret, Ulrich Roos, Sandra Schorderet Weber
  • Publication number: 20170240536
    Abstract: The present invention concerns compounds of formula (I) or an N-oxide or salt thereof and their use for controlling parasites in and on warm-blooded animals or fish.
    Type: Application
    Filed: November 6, 2015
    Publication date: August 24, 2017
    Inventors: Noëlle Gauvry, Thomas Goebel, Steve Nanchen, Jean-Luc Perret, Ulrich Roos, Sandra Schorderet Weber
  • Patent number: 9491941
    Abstract: The present invention relates to new compounds of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on vertebrates.
    Type: Grant
    Filed: December 20, 2013
    Date of Patent: November 15, 2016
    Assignee: NOVARTIS TIERGESUNDHEIT AG
    Inventors: Emilie Dupont, Noelle Gauvry, Steve Nanchen, Chikako Ogawa, Chouaib Tahtaoui
  • Publication number: 20160024062
    Abstract: The invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on warm-blooded animals.
    Type: Application
    Filed: October 1, 2015
    Publication date: January 28, 2016
    Applicant: NOVARTIS TIERGESUNDHEIT AG
    Inventors: Noelle Gauvry, Steve Nanchen
  • Publication number: 20150320044
    Abstract: The present invention relates to new compounds of formula (I) wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on vertebrates.
    Type: Application
    Filed: December 20, 2013
    Publication date: November 12, 2015
    Inventors: Emilie Dupont, Noelle Gauvry, Steve Nanchen, Chikako Ogawa, Chouaib Tahtaoui
  • Publication number: 20150272931
    Abstract: The present invention concerns the use of clothianidin for controlling sea lice in a fish population, which comprises feeding clothianid to the fish population according to a specific regime as outlined in the specification and claims. The process is especially suited for the treatment of salmon and provides prolonged effective protection against sea lice at sea.
    Type: Application
    Filed: October 24, 2013
    Publication date: October 1, 2015
    Inventors: Jacques BOUVIER, Steve NANCHEN, Jean-Luc PERRET
  • Patent number: 9044389
    Abstract: The invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on warm-blooded animals.
    Type: Grant
    Filed: January 6, 2014
    Date of Patent: June 2, 2015
    Assignee: Novartis Tiergesundheit AG
    Inventors: Steve Nanchen, Noelle Gauvry, Thomas Goebel
  • Publication number: 20150125509
    Abstract: The present invention concerns the use of lufenuron for controlling sea lice in a fish population, which comprises feeding lufenuron to the fish population according to a specific regime as outlined in the specification and claims. The process is especially suited for the treatment of salmon and provides prolonged effective protection against sea lice at sea.
    Type: Application
    Filed: May 8, 2013
    Publication date: May 7, 2015
    Inventors: David Blaser, Jacques Bouvier, Martin Fink, John Gerard Mchenery, Steve Nanchen
  • Patent number: 9023836
    Abstract: The present invention relates to the use of compounds of formula wherein the variables are as defined in the description, in the free form or in salt form, for controlling sea lice on fish.
    Type: Grant
    Filed: June 15, 2011
    Date of Patent: May 5, 2015
    Assignee: Novartis Tiergesundheit AG
    Inventors: Jean-Luc Perret, David Blaser, Steve Nanchen
  • Publication number: 20140343085
    Abstract: The present invention relates to the use of compounds of formula (I), wherein the variables are as defined in the description, in the free form or in salt form, for the manufacture of a medicament for controlling ectoparasites on a warm-blooded animal, wherein said medicament is administered orally to the animal at a dose of from 0.1 to 100 mg/kg from 30 minutes before to 3 hours after feeding the animal with an animal food.
    Type: Application
    Filed: November 23, 2012
    Publication date: November 20, 2014
    Applicant: Novartis AG
    Inventors: Cyril Desevaux, Martin Jung, Caroline Kablitz, Steve Nanchen
  • Patent number: 8822466
    Abstract: The invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on vertebrates.
    Type: Grant
    Filed: March 9, 2012
    Date of Patent: September 2, 2014
    Assignee: Novartis AG
    Inventors: Noëlle Gauvry, Steve Nanchen
  • Publication number: 20140120147
    Abstract: The invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on warm-blooded animals.
    Type: Application
    Filed: January 6, 2014
    Publication date: May 1, 2014
    Applicant: NOVARTIS AG
    Inventors: Steve NANCHEN, Noelle GAUVRY, Thomas GOEBEL
  • Patent number: 8653116
    Abstract: The invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on warm-blooded animals.
    Type: Grant
    Filed: January 14, 2013
    Date of Patent: February 18, 2014
    Assignee: Novartis AG
    Inventors: Steve Nanchen, Noelle Gauvry, Thomas Goebel
  • Publication number: 20130345221
    Abstract: The invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on vertebrates.
    Type: Application
    Filed: March 9, 2012
    Publication date: December 26, 2013
    Applicant: NOVARTIS AG
    Inventors: Noëlle Gauvry, Steve Nanchen
  • Publication number: 20130324538
    Abstract: The invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on warm-blooded animals.
    Type: Application
    Filed: February 9, 2012
    Publication date: December 5, 2013
    Inventors: Noëlle Gauvry, Steve Nanchen
  • Patent number: 8592418
    Abstract: The present invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on vertebrates.
    Type: Grant
    Filed: June 11, 2011
    Date of Patent: November 26, 2013
    Assignee: Novartis AG
    Inventors: Steve Nanchen, Noelle Gauvry, Thomas Goebel
  • Publication number: 20130131053
    Abstract: The invention relates to new isoxazoline compounds of formula wherein the variables have the meaning as indicated in the claims; in free form and in salt form; and optionally the enantiomers and geometrical isomers thereof. The compounds of formula (I) are useful in the control of parasites, in particular ectoparasites, in and on warm-blooded animals.
    Type: Application
    Filed: January 14, 2013
    Publication date: May 23, 2013
    Inventors: Steve NANCHEN, Noelle GAUVRY, Thomas GOEBEL